insights_auto
Why is 600535 up 2,22%?
Dive Deeperchevron_right
600535:SHA
Tasly Pharmaceutical Group Co Ltd
CN¥14,28
arrow_upward
+2,22%(+0,31) 1D
14 Okt., 15:00:01 GMT+8 · CNY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 600535...
Open
CN¥14,00
High
CN¥14,31
Low
CN¥13,93
Mkt. cap
21,24 mjd
Avg. vol.
11,81 m
Volume
15,47 m
Dividend
2,38%
Quarterly dividend
CN¥0,09
Ex-dividend date
29 Mei 2026
P/E ratio
17,44
52-wk high
CN¥16,24
52-wk low
CN¥12,90
EPS
CN¥0,82
Shares outstanding
1,51 mjd
No. of employees
11 k
Open
CN¥14,00
High
CN¥14,31
Low
CN¥13,93
Mkt. cap
21,24 mjd
Avg. vol.
11,81 m
Volume
15,47 m
Dividend
2,38%
Quarterly dividend
CN¥0,09
Ex-dividend date
29 Mei 2026
P/E ratio
17,44
52-wk high
CN¥16,24
52-wk low
CN¥12,90
EPS
CN¥0,82
Shares outstanding
1,51 mjd
No. of employees
11 k
Related stocks
News stories
From web sources and news partners
GlobeNewswire
·
33 minute gelede
Owlting Group (NASDAQ: OWLS) and Decaf Open U.S. Dollar Accounts Beyond the United States on OwlPay Harbor
Reuters
·
26 minute gelede
Mapping the Market: Dow eyes another run at a rally
Investor's Business Daily
·
1 uur gelede
Dow Futures Rise; ASML Earnings Beat, CPI Inflation Due
Seeking Alpha
·
3 uur gelede
Dow Jones Industrial Average Monitor Update - A Look At 30 U.S. Large-Caps
Profile
Tasly is a Chinese pharmaceutical company based in the city of Tianjin. It was established in 1994 and is notably producing traditional Chinese medicines.
It has a turnover of 4 billion US dollars, 10,000 employees and is listed on the Shanghai Stock Exchange.
In 2009, Chinese pharmacologist Li Lianda claimed that a key product made by Tasly was unsafe. Tasly sued Li in 2013, alleging that Li's claim was baseless and was motivated by his financial and employment relations with Guangzhou Pharmaceutical, a direct competitor of Tasly. In September 2014, the Tianjin High People's Court ruled in favour of Tasly and ordered Li to issue an apology and pay Tasly 300,000 yuan in compensation.
In February 2017, Tasly announced plans to form a joint venture with American multi-level marketing company Herbalife. Wikipedia
About Tasly Pharmaceutical Group Co Ltd